Luxiq (betamethasone valerate) Foam

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved June 1999

Specific Treatments:

Dermatology

Therapeutic Areas

General Information

Luxiq (betamethasone valerate) Foam has been approved for the treatment of dermatoses of the scalp.